Document is current
Any future updates will be listed below
-
Authors
Moecker, Robert
Weissenborn, Marina
Klingenberg, Anja
Wirbka, Lucas
Fuchs, Andreas
Eickhoff, Christiane
Mueller, Uta
Schulz, Martin
Kaufmann-Kolle, Petra
,
Auerbach, Anja
Braun, Dorit
Doehler, Catharina
Donner, Susanne
Fink, Stefan
Frasch, Jona
Honscha, Christine
Kuhn, Urs Dieter
Maetzler, Mike
Maywald, Ulf
Meid, Andreas D.
Moeckel, Anke
Ruff, Carmen
Stoll, Felicitas
Wagner, Kathrin
Haefeli, Walter E.
Seidling, Hanna M.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 25 July 2022
First Online: 6 August 2022
Declarations
:
: All HCPs participated voluntarily and gave their informed consent before being included in this study. The study was conducted in accordance with the current version of the Declaration of Helsinki. Ethical approvals were obtained from the responsible Ethics Committee of the Medical Faculty of Heidelberg University (reference no.: S-142/2019 and S-230/2019).
: Not applicable.
: RM, MW, LW, WEH, and HMS declare they have received funding from the AOK PLUS. AK, PKK, and JF received funding from Department of Clinical Pharmacology and Pharmacoepidemiology. Furthermore, the following members of the ARMIN study group have contributed to program development and conduct: CE, UM, MS, AF, DB, UM, CD, MM, AA, UDK, AM, CH, SD, SF, KW.
